Copy For Citation
Küp A., Çelik M., Uslu A., Külahçıoğlu Ş., Tükenmez Tigen E., Demir S., ...More
Troia Medical Journal, vol.3, no.3, pp.96-99, 2022 (Peer-Reviewed Journal)
-
Publication Type:
Article / Article
-
Volume:
3
Issue:
3
-
Publication Date:
2022
-
Doi Number:
10.55665/troiamedj.1151301
-
Journal Name:
Troia Medical Journal
-
Journal Indexes:
Asos İndeks
-
Page Numbers:
pp.96-99
-
Marmara University Affiliated:
Yes
Abstract
Objective: Electrocardiographic alterations were investigated following the second dosage of COVID-19 mRNA vaccination. Methods: A total of 260 individuals after two doses of COVID-19 vaccine with Pfizer-BioNTech were included in the study. The electrocardiographic parameters recorded at baseline and approximately one week later after two doses of Pfizer-BioNTech vaccine were compared for all patients. Results: PR interval was increased and QTc maximum interval was decreased significantly after second dose COVID-19 mRNA vaccination. Baseline and post-second dose vaccination states regarding P wave dispersion and QT dispersion/Tp-e interval which have been recognized to imply inhomogeneous atrial conduction and heterogeneity in ventricular repolarization were similar between groups. Conclusion: Our findings suggest that there should be no concern related to asymptomatic involvement of the myocardium subsequent the second dose of COVID-19 mRNA vaccination.